Private Equity
Cambridge, Massachusetts-based Verve Therapeutics, a next-generation cardiovascular company, has named Dr. Andrew Bellinger as chief scientific officer. Dr. Bellinger is a general cardiologist at Brigham and Women’s Hospital. Verve’s backers include GV, ARCH Venture Partners, F-Prime Capital and Biomatics Capital.
3 min read · 03 October 2019
Geneoscopy Inc, a developer of diagnostic tests for gastrointestinal health, has secured $6.9 million in Series A financing. Cultivation Capital and NT Investments led the round.
1 min read · 02 October 2019
The Empire State's pension vehicle made a $15 million commitment to Primary Venture Partner’s Primary Select Fund I in August.
2 min read · 02 October 2019
Chicago-based NOCD, a digital behavioral health company, has secured $4 million in Series A funding. Chicago Ventures led the round with participation from other investors that included 7Wire Ventures, Meridian Street Capital and Hyde Park Angels.
1 min read · 02 October 2019
The numbers for the strategy aren’t favorable, but lenders remain positive
3 min read · 02 October 2019
2 min read · 01 October 2019
However, the U.S. ranks atop with 14.4 percent historical return that includes data from active and liquidated VC funds, based on 350 active funds
2 min read · 01 October 2019
Denver-based BurstIQ, a provider of secure blockchain solutions for the healthcare industry, has raised $5.5 million in Series A financing. Elsewhere Partners led the round.
1 min read · 01 October 2019
San Diego-based sleep solutions provider Sleep Data has secured $6 million in funding. The investor was HCAP Partners. The capital will be used to support the growth of Sleep Data's subsidiary Better Night.
1 min read · 01 October 2019
3 min read · 01 October 2019
